We are live on
!
Find out more
Nicholas Hoffman & Company Portfolio holdings
AUM
$4.74B
Turnover
9.12%
1-Year Est. Return
18.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
(+7.3%)
Cap. Flow
+$3.23M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.37M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$874K |
| 3 |
SLB Ltd
SLB
|
+$547K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$522K |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$639K |
| 2 |
Chevron
CVX
|
+$538K |
| 3 |
GSK
GSK
|
+$425K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$359K |
| 5 |
TSMC
TSM
|
+$339K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.6% |
| 2 | Consumer Staples | 12.2% |
| 3 | Technology | 10.83% |
| 4 | Financials | 9.85% |
| 5 | Healthcare | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Wells Fargo
WFC
$248B
| $1.3M | 0.51% |
21,475
-1,478
| -6% | -$83.5K |
2016 Q2
6 quarters
|
|
52
PNC Financial Services
PNC
$85.7B
| $1.29M | 0.51% |
8,970
-760
| -8% | -$105K |
2016 Q2
6 quarters
|
|
53
ConocoPhillips
COP
$170B
| $1.29M | 0.51% |
23,563
+95
| +0.4% | +$4.89K |
2016 Q4
4 quarters
|
|
54
Norfolk Southern
NSC
$73B
| $1.26M | 0.49% |
8,665
-31
| -0.4% | -$4.16K |
2016 Q2
6 quarters
|
|
55
Bank of America
BAC
$362B
| $1.2M | 0.47% |
40,600
+7,277
| +22% | +$201K |
2016 Q2
6 quarters
|
|
56
Mondelez International
MDLZ
$80.4B
| $1.14M | 0.45% |
26,520
+545
| +2% | +$22.9K |
2016 Q2
6 quarters
|
|
57
SPDR Gold Trust
GLD
$142B
| $1.11M | 0.44% |
9,012
-120
| -1% | -$14.5K |
2016 Q2
6 quarters
|
|
58
Travelers Companies
TRV
$80.1B
| $1.11M | 0.43% |
8,151
-109
| -1% | -$14.4K |
2016 Q2
6 quarters
|
|
59
DELISTED
Barclays Bank Plc
BCS.PRD.CL
| $1.1M | 0.43% |
41,165
-3,133
| -7% | -$83.4K |
2017 Q3
1 quarter
|
|
60
Medtronic
MDT
$122B
| $1.09M | 0.43% |
13,457
-410
| -3% | -$32.8K |
2016 Q2
6 quarters
|
|
61
US Bancorp
USB
$89.4B
| $1.08M | 0.42% |
20,087
+120
| +0.6% | +$6.46K |
2016 Q2
6 quarters
|
|
62
Eli Lilly
LLY
$1.12T
| $1.07M | 0.42% |
12,675
| – | – |
2016 Q2
6 quarters
|
|
63
Northrop Grumman
NOC
$71B
| $1.04M | 0.41% |
3,382
+5
| +0.1% | +$1.5K |
2016 Q2
6 quarters
|
|
64
AstraZeneca
AZN
$259B
| $1.02M | 0.4% |
14,700
| – | – |
2016 Q2
6 quarters
|
|
65
Consolidated Edison
ED
$40.6B
| $1.02M | 0.4% |
12,009
+2
| +0% | +$172 |
2016 Q2
6 quarters
|
|
|
66
SLB Ltd
SLB
$71.8B
| $988K | 0.39% |
14,655
+8,444
| +136% | +$547K |
2016 Q2
6 quarters
|
|
67
Visa
V
$750B
| $985K | 0.39% |
8,640
+184
| +2% | +$20.3K |
2016 Q2
6 quarters
|
|
68
3M
MMM
$85.3B
| $983K | 0.39% |
4,996
+128
| +3% | +$24.6K |
2016 Q2
6 quarters
|
|
|
CARO
69
DELISTED
Carolina Financial Corp.
CARO
| $965K | 0.38% |
25,977
| – | – |
2016 Q2
6 quarters
|
|
70
Honda
HMC
$44.2B
| $950K | 0.37% |
27,865
-25
| -0.1% | -$808 |
2016 Q2
6 quarters
|
|
71
Lowe's Companies
LOW
$110B
| $940K | 0.37% |
10,117
+30
| +0.3% | +$2.48K |
2017 Q3
1 quarter
|
|
72
McKesson
MCK
$116B
| $935K | 0.37% |
5,995
-45
| -0.7% | -$6.67K |
2016 Q4
4 quarters
|
|
73
Kroger
KR
$37B
| $929K | 0.36% |
33,840
-1,205
| -3% | -$28.1K |
2017 Q2
2 quarters
|
|
74
Walt Disney
DIS
$191B
| $920K | 0.36% |
8,556
-516
| -6% | -$53.2K |
2016 Q2
6 quarters
|
|
75
Amazon
AMZN
$2.75T
| $878K | 0.34% |
15,020
+600
| +4% | +$33K |
2016 Q2
6 quarters
|
|
Similar funds
PTC
Nicholas Hoffman & Company's Q4 2017 Portfolio in Review
As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 38% a quarter earlier, followed by Consumer Staples and Technology.
- Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
- Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
- Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
- Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
- Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
- Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
- Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.
Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.